Skip to main content
SpringerLink
Log in

Eisenstoffwechsel

  • Chapter
Transfusionsmedizin und Immunhämatologie

  • 6819 Accesses

Zusammenfassung

Eisen ist als Spurenelement ein essenzieller Nahrungsbestandteil, der für die Aufrechterhaltung des Zellmetabolismus und der aeroben Atmung unentbehrlich ist. Die notwendige exogene Zufuhr von Eisen ist Voraussetzung für eine ausreichende Erythropoese. Auch als Coenzym und Katalysator lebenswichtiger biochemischer Reaktionsabläufe ist Eisen für den humanen Organismus unverzichtbar

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Alleyne M, Horne MK, Miller JL (2008) Individualized treatment for iron deficiency anemia in adults. Am J Med 121:943–948

    Article  PubMed  Google Scholar 

  2. Angelucci E, Barosi G, Camaschella C, Cappelini MS, Cazzola M, Galanello R, Marchetti M, Piga A, Tura S (2008) Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Hematologica 93:741–752

    Article  Google Scholar 

  3. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY (2006) Bone morphogenetic protein signalling by hemojuvelin regulates hepcidin expression. Nat Genet 38:531–539

    Article  PubMed  CAS  Google Scholar 

  4. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY (2007) Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Investig 117:1933–1939

    Article  PubMed  CAS  Google Scholar 

  5. Ballas SK (2001) Iron overload is a determinant of morbidity an mortality in adult patients with sickle cell disease. Semin Hematol 38 (Suppl 1):30–36

    Article  PubMed  CAS  Google Scholar 

  6. Beutler E, Hoffbrand AV, Cook JD (2003) Iron deficiency and overload. Hematology Am Soc Hematol Educ Program: 40–61

    Google Scholar 

  7. Bosserhoff AK, Hellerbrand C, Buettner R (2001) Clinical and genetic aspects of hereditary hemochromatosis. Pathologe 22:191–196

    Article  PubMed  CAS  Google Scholar 

  8. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. New Engl J Med 331:567–573

    Article  PubMed  CAS  Google Scholar 

  9. Brittenham GM, Klein HG, Kushner JP, Ajioka RS (2001) Preserving the national blood supply. Hematology Am Soc Hematol Educ Program: 422–432

    Google Scholar 

  10. Brugnara C (2000) Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoetic function. Crit Rev Clin Lab Sci 37:93–130

    Article  PubMed  CAS  Google Scholar 

  11. Buttarello M, Temporin V, Ceravolo R, Farina G, Bulian P (2004) The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100. Am J Clin Pathol 121:491–495

    Article  Google Scholar 

  12. Camaschella C, Roetto A, Calì A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15

    Article  PubMed  CAS  Google Scholar 

  13. Carlsson A (2009) Hereditary hemochromatosis: a neglected diagnosis in orthopedics. Acta Orthopaedica 80:371–374

    Article  PubMed  Google Scholar 

  14. Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schöniger-Hekele M, Hackl F, Polli C, Rasoul-Rockenschaub S, Müller C, Wrba F, Gangl A, Ferenci P (2003) Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol 98:442–447

    Article  PubMed  CAS  Google Scholar 

  15. Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, Swinkels DW, Burgner DP (2008) An insight into relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS ONE 3:e4030

    Article  PubMed  CAS  Google Scholar 

  16. Ciacci C, Sabbatini F, Cavallaro R, Castiglione F, Di Bella S, Iovino P, Palumbo A, Tortora R, Amoruso D, Mazzacca g (2004) Helicobacter pylori impairs iron adsorption in infected individuals. Dig Liver Dis 36:455–460

    Article  PubMed  CAS  Google Scholar 

  17. Clark P, Britton JB, Powell LW (2010) The diagnosis and management of hereditary haemochromatosis. Clin Biochem Rev 31:3–8

    PubMed  Google Scholar 

  18. Cook JD (2005) Diagnosis and management of iron deficiency anaemia. Best Pract Res Clin Haematol 18:319–332

    Article  PubMed  CAS  Google Scholar 

  19. Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, Jeffrey GP, McCaughan GW, Kerlin P, Powell LW, Elias EE (2004) Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 39:1655–1662

    Article  PubMed  Google Scholar 

  20. Crichton RR, Wilmet S, Legssyer R, Ward RJ (2002) Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91:9–18

    Article  PubMed  CAS  Google Scholar 

  21. Cuijpers ml, Raymakers RA, Mackenzie MA, de Witte TJ, Swinkels DW (2010) Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome. Br J Haematol 149:322–333

    Article  PubMed  CAS  Google Scholar 

  22. Dar FS, Faraj W, Zaman MB, Bartlett A, Bomford A, O’Sullivan A, O’Grady J, Heneghan M, Rela M, Heaton ND (2009) Outcome of liver transplantation in hereditary hemochromatosis. Transpl Int 22:717–724

    Article  PubMed  Google Scholar 

  23. Davies PS, Zhang AS, Anderson EL, Roy CN, Lampson MA, McGraw TE, Enns CA (2003) Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. Biochem J 373:145–153

    Article  PubMed  CAS  Google Scholar 

  24. De Domenico I, McVey Ward D, Kaplan J (2008) Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9:72–81

    Article  PubMed  CAS  Google Scholar 

  25. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-ß family signalling. Nature 425:577–584

    Article  PubMed  CAS  Google Scholar 

  26. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1:191–200

    Article  PubMed  CAS  Google Scholar 

  27. Edgren G, Reilly M, Hjalgrim H, Nam Tran T, Rostgaard K, Adami J, Titlestad K, Shanwell A, Melbye M, Nyren O (2008) Donation frequency, iron loss, and risk of cancer. J Nat Cancer Inst 100:572–579

    Article  PubMed  Google Scholar 

  28. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class-I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408

    Article  PubMed  CAS  Google Scholar 

  29. Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472–1477

    Article  PubMed  CAS  Google Scholar 

  30. Files B, Brambilla D, Kutlar A, Miller S, Vichinsky E, Wang W, Granger S, Adams RJ (2002) Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol 24:284–290

    Article  PubMed  Google Scholar 

  31. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, Markianos K, Andrews NC, Fleming MD (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40:569–571

    Article  PubMed  CAS  Google Scholar 

  32. Franck S, Linssen J, Messinger M, Thomas L (2004) Clinical utility of the RET-Y in the diagnosis of iron-restricted erythropoesis. Clin Chem 50:1240–1242

    Article  PubMed  CAS  Google Scholar 

  33. Galy B, Ferring-Appel D, Kaden S, Gröne HJ, Hentze MW (2008) Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab 7:79–85

    Article  PubMed  CAS  Google Scholar 

  34. Ganz T, Olbina G, Girelli D, Nemeth E, Westermann M (2008) Immunoassay for human serum hepcidin. Blood 112:4292–4297

    Article  PubMed  CAS  Google Scholar 

  35. Gattermann N (2008) Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload. Int J Hematol 88:24–29

    Article  PubMed  Google Scholar 

  36. Gattermann N (2009) The treatment of secondary hemochromatosis. Dtsch Arztebl Int 106:499–504

    PubMed  Google Scholar 

  37. Gattermann N, Porter J, Lopes LF, Seymour J (2005) Consensus statement on iron overload in myelodysplastic syndromes. Hematol Oncol Clin 19 (Suppl 1):18–25

    Google Scholar 

  38. Goswami T, Andrews NC (2006) Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281:28494–28498

    Article  PubMed  CAS  Google Scholar 

  39. Gottschalk R, Neeck G, Wigand R, Vogtherr B, Kaltwasser JP (1997) Die hämochromatotische Arthropathie: eine frühe Manifestation genetischer Hämochromatose. Z Rheumatol 56:156–162

    Article  PubMed  CAS  Google Scholar 

  40. Grosse R, Lund U, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Lielsen P (2005) Non-transferrin-bound iron during blood transfusion cycles in beta-thalassämia major. Ann NY Acad Sci 1054:429–432

    Article  PubMed  CAS  Google Scholar 

  41. Halliwell B, Gutteridge JMC (1999) Free radicals in Biology and Medicine. Oxford University Press, New York

    Google Scholar 

  42. Hellerbrand C, Bosserhoff AK, Seegers S, Lingner G, Wrede C, Lock G, Schölmerich J, Büttner R (2001) Mutation analysis of the HFE gene in German hemochromatosis patients and controls using SSCP-based capillary elektophoresis and a new PCR-ELISA technique. Scand J Gastroenterol 36:1211–1216

    Article  PubMed  CAS  Google Scholar 

  43. Hemochromatosis. In: Online Mendelian Inheritance in Man, OMIM. McKusick-Nathans Institute for Genetic Medicine 2000, Baltimore. http://www.ncbi.nlm.nih.gov/omim/, Zugriff am 10.05.2004

  44. Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285–297

    Article  PubMed  CAS  Google Scholar 

  45. Hooper JD, Campagnolo L, Goodarzi G, Truong TN, Stuhlmann H, Quigley JP (2003) Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. Biochem J 373:689–702

    Article  PubMed  CAS  Google Scholar 

  46. Iolascon A, De Falco L, Beaumont C (2009) Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Hematologica 94:395–408

    Article  CAS  Google Scholar 

  47. Ismail MK, Martinez-Hernandez A, Schichman S, Chaudhry S, Waters B (2009) Transplantation of a liver with the C282Y mutation into a recipient heterozygous for H63D results in iron overload. Am J Med Sci 337:138–142

    Article  PubMed  Google Scholar 

  48. Jeffrey G, Adams PC (1999) Blood from patients with hereditary hemochromatosis – a wasted resource? Transfusion 39:549–550

    Article  PubMed  CAS  Google Scholar 

  49. Johnson MB, Enns CA (2004) Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104:4287–4293

    Article  PubMed  CAS  Google Scholar 

  50. Keel SB, Abkowitz JL (2009) The microcytic red cell and the anemia of inflammation. N Engl J Med 361:1904–1906

    Article  PubMed  CAS  Google Scholar 

  51. Keel SB, Doty RT, Yang Z, Quigley, JG, Chen J, Knoblaugh S, Kingsley PD, De Domenico I, Vaughn MB, Kaplan J, Palis J, Abkowitz JL (2008) A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 319:825–828

    Article  PubMed  CAS  Google Scholar 

  52. Kemna EH, Tjalsma H, Willems HL, Swinkels DW (2008) Hepcidin: from discovery to differential diagnosis. Haematologica 93:90–97

    Article  PubMed  CAS  Google Scholar 

  53. Kohan A, Niborski R, Daruich J, Rey J, Bastos F, Amerise G, Herrera R, Garcia M, Olivera W, Santarellei MT, Avalos JS, Findor J (2000) Erythrocytapheresis withb recombinant human erythropoietin in hereditary hemochromatosis therapy: a new alternative. Vox Sanguinis 79:40–45

    Article  PubMed  CAS  Google Scholar 

  54. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J (2008) Body iron metabolism and pathophysiology of iron overload. Int J Hematol 88:7–15

    Article  PubMed  CAS  Google Scholar 

  55. Koliaraki V, Marinou M, Vassilakopoulos TP, Vavourakis E, Tsochatzis E, Pangalis GA, Papatheodoridis G, Stamoulakatou A, Swinkels DW, Papanikolaou G, Mamalaki A (2009) A novel immunological assay for hepcidin quantification in serum. PLoS ONE 4:e4581

    Article  PubMed  CAS  Google Scholar 

  56. Kong WN, Zhao SE, Duan XL, Yang Z, Qian ZM, Chang YZ (2008) Decreased DMT-1 and increased ferroportin 1 expression is the mechanism of reduced iron retention in macrophages. J Cell Biochem 104:629–641

    Article  PubMed  CAS  Google Scholar 

  57. Kowdley KV, Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilski ml, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N; National Hemochromatosis Transplant Registry (2005) Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 129:494–503

    PubMed  Google Scholar 

  58. Lin L, Nemeth E, Goodnough JB, Thapa DR, Gabayan V, Ganz T (2008) Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis 40:122–131

    Article  PubMed  CAS  Google Scholar 

  59. Luten M, Roerdinkholder-Stoelwinder B, Rombout-Sestrienkova E, de Grip WJ, Bos HJ, Bosman GJ (2008) Red cell concentrates of hemochromatosis patients comply with the storage guidelines for transfusion purposes. Transfusion 48:436–441

    Article  PubMed  CAS  Google Scholar 

  60. MacDougall IC, Cavill U, Hulme B, Brain B, McGregor E, McKay P, Sanders E, Coles GA, Williams JD (1992) Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ 304:225–226

    Article  PubMed  CAS  Google Scholar 

  61. Maghsudlu M, Nasizadeh S, Toogeh GR, Zandieh T, Parandoush S, Rezayani M (2008) Short-term ferrous sulfate supplementation in female blood-donors. Transfusion 48:1192–1197

    Article  PubMed  Google Scholar 

  62. Magnussen K, Bork N, Asmussen L (2008) The effect of a standardized protocol for iron supplementation to blood donors low in hemoglobin concentration. Transfusion 48:749–754

    Article  PubMed  CAS  Google Scholar 

  63. Mahida VI, Bhatti A, Gupte SC (2008) Iron status of regular voluntary blood donors. Asian J Transf Sci 2:9–12

    Article  CAS  Google Scholar 

  64. Malcovati L, Della Porta mg, Cazzola M (2006) Predicting survival and leukemic evolutin in patients with myelodysplastic syndrome. Hematologica 91:1588–1590

    Google Scholar 

  65. McCann JC, Ames BN (2007) An overview of evidence for a causal relation between iron deficiency during developement and deficits in cognitive or behavorial function. Am J Clin Nutr 85:931–945

    PubMed  CAS  Google Scholar 

  66. Meier P, Schuff-Werner P, Steiner M (2005) Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany. Clin Lab 51:539–543

    PubMed  CAS  Google Scholar 

  67. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A (2001) Autosomaldominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619–623

    PubMed  CAS  Google Scholar 

  68. Montosi G, Paglia P, Garuti C, Guzman CA, Bastin JM, Colombo MP, Pietrangelo A (2000) Wild-type HFE in macrophages protein normalizes transferring iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 96:1125–1129

    PubMed  CAS  Google Scholar 

  69. Moore SB, Winters JL (2003) Multiple blood donations and iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 78:654

    Article  PubMed  Google Scholar 

  70. Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HG, Gordon SC, Galan MV, Tung BY, Ioannou GN, Kowdley KV (2003) Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 138:627–633

    PubMed  CAS  Google Scholar 

  71. Muncunill J, Vaquer P, Galmes A, Obrador A, Parera M, Bargay J, Besalduch J (2002) In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy. J Clin Apher 17:88–92

    Article  PubMed  CAS  Google Scholar 

  72. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology - v.1.2009: Myelodysplastic Syndromes. http://www.nccn.org/professionals/physician_gls/pdf/mds.pdf, Zugriff am 19.12.2008

  73. Nemeth E, Ganz T (2006) Hepcidin and iron-loading anemias. Haematologica 91:727–732

    PubMed  CAS  Google Scholar 

  74. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood 101:2461–2463

    Article  PubMed  CAS  Google Scholar 

  75. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron influx by binding to ferroportin and inducing its internalization. Science 306:2090–2093

    Article  PubMed  CAS  Google Scholar 

  76. Ness PM, Lipton KS (2000) Hemochromatosis: questions and answers. Am Assoc Blood Banks Bulletin: 00–2

    Google Scholar 

  77. Newman BH, Roth AJ (2005) Estimating the probability of blood donation adverse event based on 1000 interviewed whole blood donors. Transfusion 45:1715–1721

    Article  PubMed  CAS  Google Scholar 

  78. Newman BH, Newman DT, Ahmad R, Roth AJ (2006) The effect of whole-blood donor adverse events on blood donor return rates. Transfusion 46:1374–1379

    Article  PubMed  Google Scholar 

  79. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98:8780–8785

    Article  PubMed  CAS  Google Scholar 

  80. Niederau C, Fischer R, Sonnenberg A, Stremmel, W, Trampisch HJ, Strohmeyer g (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256–1262

    Article  PubMed  CAS  Google Scholar 

  81. Nielsen P, Fischer R, Buggisch P, Janka-Schaub g (2003) Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases. Br J Haematol 123:952–953

    Article  PubMed  Google Scholar 

  82. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, van Duijn CM, Heutink P (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213–214

    Article  PubMed  CAS  Google Scholar 

  83. O’Neil J, Powell L (2005) Clinical aspects of hemochromatosis. Semin Liver Dis 25:381–460

    Article  PubMed  Google Scholar 

  84. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, Sharp JJ, Fujiwara Y, Barker JE, Fleming MD (2005) Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37:1264–1269

    Article  PubMed  CAS  Google Scholar 

  85. Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol Appl Pharmacol 202:199–211

    Article  PubMed  CAS  Google Scholar 

  86. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ml, Franchini PL, Dubé MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82

    Article  PubMed  CAS  Google Scholar 

  87. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E (2005) Hepcidin in iron overload diseases. Blood 105:4103–4105

    Article  PubMed  CAS  Google Scholar 

  88. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, Nizet V, Johnson RS (2007) Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 117:1926–1932

    Article  PubMed  CAS  Google Scholar 

  89. Pietrangelo A (2004) Hereditary hemochromatosis – a new look on at an old disease. N Engl J Med 350:2383–2397

    Article  PubMed  CAS  Google Scholar 

  90. Pietrangelo A (2006) Hereditary hemochromatosis. Biochem Biophys Acta 1763:700–710

    Article  PubMed  CAS  Google Scholar 

  91. Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD (2008) High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol 84:29–33

    Article  CAS  Google Scholar 

  92. Pinsky LE, Imperatore G, Burke W (2002) Diabetes and HFE mutations: cause or coincidence? West J Med 176:114–115

    PubMed  Google Scholar 

  93. Pointon JJ, Viprakasit V, Miles KL, Livesey KJ, Steiner M, O’Riorda S, Hien TT, Merryweather-Clarke AT, Robson KJ (2003) Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload. Blood Cells Mol Dis 30:302–306

    Article  PubMed  CAS  Google Scholar 

  94. Porter JB (2001) Practible management of iron overload. Br J Haematol 115:239–252

    Article  PubMed  CAS  Google Scholar 

  95. Provan D (1999) Mechanisms and management of iron deficiency anemia. Br J Haematol 105 (Suppl 1):19–26

    PubMed  Google Scholar 

  96. Ramsay JR, Hooper JD, Folgueras AR, Velasco G, Lopez-Otin, C (2009) Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94:840–849

    Article  PubMed  CAS  Google Scholar 

  97. Remacha AF, Arrizabalaga B, Del Canizo C, Sanz G, Villegas A (2010) Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements. Ann Hematol 89:147–154

    Article  PubMed  CAS  Google Scholar 

  98. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321–323

    Article  PubMed  CAS  Google Scholar 

  99. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22

    Article  PubMed  CAS  Google Scholar 

  100. Rombout-Sestrienkova E, van Noord PA, van Deursen CT, Sybesma BJ, Nillesen-Meertens AE, Koek GH (2007) Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis. A pilot study. Transfus Apher Sci 36:261–267

    Article  PubMed  Google Scholar 

  101. Roy CN, Enns CA (2000) Iron hemostasis: new tales from the crypt. Blood 96:4020–4027

    PubMed  CAS  Google Scholar 

  102. R’zik S, Loo M, Beguin Y (2001) Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels. Haematologica 86:244–251

    PubMed  Google Scholar 

  103. Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews MC (2008) The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 7:205–214

    Article  PubMed  CAS  Google Scholar 

  104. Shander A, Cappellini MD, Goodnough LT (2009) Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sanguinis 97:185–197

    Article  PubMed  CAS  Google Scholar 

  105. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, McKie AT (2005) Identification of an intestinal heme transporter. Cell 122:789–801

    Article  PubMed  CAS  Google Scholar 

  106. Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK (2006) Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev 27:5–16

    PubMed  Google Scholar 

  107. Silber MH, Richardson JW (2003) Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 78:52–54

    Article  PubMed  Google Scholar 

  108. Silvestri L, Pagani A, Camaschella C (2008) Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111:924–931

    Article  PubMed  CAS  Google Scholar 

  109. Simon TL (2002) Iron, iron everywhere but not enough to donate. Transfusion 42:664

    Article  PubMed  Google Scholar 

  110. Steiner M, Leiendecker-Foster C, McLaren GD, Snively BM, McLaren CE, Adams PC and Eckfeldt JH (2007) Hemochromatosis (HFE) gene splice site mutation (IVS5+1 G/A) in North American Vietnamese with and without phenotypic evidence of iron overload. Translational Research 149:92–95

    Article  PubMed  CAS  Google Scholar 

  111. Steiner M, Meier P, Schuff-Werner P (2003) Hereditäre Hämochromatose: Aktuelle Erkenntnisse und Kontroversen. J Lab Med 27:266–276

    Article  CAS  Google Scholar 

  112. Steiner M, Ocran K, Genschel J, Meier P, Gerl H, Ventz M, Schneider ml, Büttner C, Wadowska K, Kerner W, Schuff-Werner P, Lochs H, Schmidt H (2002) A homozygous HFE gene splice site mutation (IVS5+1 G/A) in a hereditary hemochromatosis patient of Vietnamese origin. Gastroenterology 122:789–795

    Article  PubMed  CAS  Google Scholar 

  113. Sunder-Plassmann G, Hörl WH (1996) Safety of intravenous injection of iron saccharate in haemodialysis patients. Nephrol Dial Transplant 11:1797–1802

    Article  PubMed  CAS  Google Scholar 

  114. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, Tjalsma H (2008) Advances in quantitative hepsidin measurements by time-of-flight mass spectrometry. PLoS ONE 3:e2706

    Article  PubMed  CAS  Google Scholar 

  115. Tannapfel A, Stölzel U, Köstler E, Melz S, Richter M, Keim V, Schuppan D, Wittekind C (2001) C282Y and H63D mutation of the hemochroma-tosis gene in German porphyria cutanea tarda patients. Virchows Arch 439:1–5

    Article  PubMed  CAS  Google Scholar 

  116. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH, Eling TE, Childs R, Ganz T, Leitman SF, Fucharoen S, Miller JL (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13:1096–1101

    Article  PubMed  CAS  Google Scholar 

  117. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss g (2009) Regulation of iron homoestasis in anemia of chronic disease and iron deficient anemia: diagnostich and therapeutic implications. Blood 113:5277–5286

    Article  PubMed  CAS  Google Scholar 

  118. Thomas C, Thomas L (2002) Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 48:1066–1076

    PubMed  CAS  Google Scholar 

  119. Thomas C, Thomas L (2005) Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol 11:14–23

    Article  PubMed  CAS  Google Scholar 

  120. Valore EV, Ganz T (2008) Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis 40:132–138

    Article  PubMed  CAS  Google Scholar 

  121. Viatte L, Lesbordes-Brion JC, Lou DQ, Bennoun M, Nicolas G, Kahn A, Canonne-Hergaux F, Vaulont S (2005) Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood 105:4861– 4864

    Article  PubMed  CAS  Google Scholar 

  122. Wang RH, Li C, Xu X, Zheng Y, Xiao C, Zerfas P, Cooperman S, Eckhaus M, Rouault T, Mishra L, Deng CX (2005) A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2:399–409

    Article  PubMed  CAS  Google Scholar 

  123. West AP Jr, Bennett MJ, Sellers VM, Andrews NC, Enns CA, Bjorkman PJ (2000) Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 275:38135–38138

    Article  PubMed  CAS  Google Scholar 

  124. Wood JC (2009) Cardiac complications in thalassemia major. Hemoglobin 33:S81–86

    Article  PubMed  CAS  Google Scholar 

  125. Wrighting DM, Andrews NC (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108:3204–3209

    Article  PubMed  CAS  Google Scholar 

  126. Wrighting DM, Andrews NC (2008) Iron homeostasis and erythropoiesis. Curr Top Dev Biol 82:141–167

    Article  PubMed  CAS  Google Scholar 

  127. Zhang AS, Davies PS, Carlson HL, Enns CA (2003) Mechanisms of HFEinduced regulation of iron homeostasis:Insights from the W81A HFE mutation. Proc Natl Acad Sci USA 100:9500–9505

    Article  PubMed  CAS  Google Scholar 

  128. Zhang AS, Anderson SA, Meyers KR, Hernandez C, Eisenstein RS, Enns CA (2007) Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J Biol Chem 282:12547–12556

    Article  PubMed  CAS  Google Scholar 

  129. Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh MC, Rouault TA (2009) A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 9:461–473

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsklinikum Rostock AöR, Ernst-Heydemann-Str. 6, 18057, Rostock

    Prof. Dr. P. Schuff-Werner

Authors
  1. Prof. Dr. P. Schuff-Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Transfusionsmedizin, Universitätsklinikum Rostock AöR, Ernst-Heydemann-Str. 6, 18057, Rostock

    Volker Kiefel

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schuff-Werner, P. (2010). Eisenstoffwechsel. In: Kiefel, V., Mueller-Eckhardt, C. (eds) Transfusionsmedizin und Immunhämatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12765-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-12765-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-12764-9

  • Online ISBN: 978-3-642-12765-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation